Chronic Conditions

Qvin’s Q-Pad Makes History with First FDA Approval for Menstrual Blood Health Testing

Biotech research company Qvin has announced the FDA clearance of its innovative Q-Pad and A1c Test, marking a significant advancement in women’s health technology. This approval introduces a new method of health monitoring for millions of American women, particularly those living with diabetes, through menstrual blood testing. The Q-Pad offers a less invasive and more accessible alternative to traditional venous blood draws.…

Allara Raises $10M in Series A Funding to Address Care Gap for Women with Chronic Hormonal Conditions

Allara, a virtual care platform serving women of reproductive age with chronic hormonal conditions, has announced a $10M Series A funding round led by GV (Google Ventures). Participants in the funding round include Great Oaks Venture Capital, Humbition, Vanterra, Gaingels, and individual investors such as Tom Lee from One Medical and Maggie Sellers. Additionally, Frédérique Dame, GV’s General Partner, will join Allara’s…

New Report by Parsley Health Reveals Urgent Need for Healthcare Solutions that Support Women in the Workplace

A recent Parsley Health survey has uncovered alarming trends in the health of women in the workforce. The survey, which included over 1,200 full-time employed and insured women aged 18-60, sheds light on critical issues impacting both women’s well-being and employers’ productivity. Missed Workdays and Reduced Productivity A concerning 43% of women surveyed admitted to missing one or more workdays in the…

Eureka Health Raises $7M in Seed Funding to Connect Chronically Ill Patients

Zain Memon, a tech executive, established Eureka Health to address the lack of support for his mother, who was diagnosed with the rare condition MSA (similar symptoms to Parkinson’s). The startup recently secured a $7M in seed round led by Khosla Ventures. Other participants include South Park Commons, Bling Capital, SciFi VC, Able Partners and Bow Capital participated as well as 23andMe…

Parsley Health Launches Comprehensive Women’s Health Program for Employers

Parsley Health has launched a new program that focuses on providing comprehensive care for working women with complex and chronic health concerns. The program aims to deliver exceptional health outcomes by addressing a wide range of medical conditions, including autoimmune, gastrointestinal, cardiometabolic, behavioral health, and hormonal conditions. It covers women throughout their reproductive health to menopause and combines high-touch, tech-enabled virtual care…

Transdermal Diagnostics Picks Up £1.1M for Its Needle-free Continuous Glucose Monitor

Transdermal Diagnostics, a University of Bath spinout company developing technology to monitor glucose levels non-invasively, has received £800K in seed funding and a £300K grant from Innovate UK. The seed round was led by QUBIS, which specialises in innovation focused spin-out companies, and includes Pioneer Group, Immetric, Bristol Private Equity Club and Science Angel Syndicate. In March 2022, the researchers – led…

Women’s Health Primary Care Company Alpha Medical Adds Diabetes Treatment and Care Services

Virtual primary care company Alpha Medical is expanding its services to treat Prediabetes, Type 2 Diabetes, and Gestational Diabetes through affordable and flexible treatment plans. The new offering includes clinical care offerings to help treat and screen for Prediabetes, Type 2 Diabetes, and screen for Gestational Diabetes.  With this new service, Alpha now offers a full-service approach to diabetes treatment, including the…

Swing Therapeutics Kicks off the Third Study for Its Fibromyalgia Digital Therapeutic 

Fibromyalgia is a condition that causes widespread pain all over the body, sleep problems, fatigue, and often emotional and mental distress. People with fibromyalgia may be more sensitive to pain than people without fibromyalgia. The cause of fibromyalgia is not known, but it can be effectively treated and managed. In the U.S. around 4 million people are affected. Women are twice as…